Stay updated on Neoadjuvant Immunotherapy Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Neoadjuvant Immunotherapy Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neoadjuvant Immunotherapy Combo in Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The site revision changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T06:37:13.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The record was updated to version 19, and the study’s results are now posted. Results sections include outcome measures, participant flow, baseline characteristics, and adverse events.
    Difference
    2%
    Check dated 2026-10-25T06:54:30.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T05:41:17.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T08:31:26.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The record now indicates that study results have been submitted, replacing the previous status that no results were posted.
    Difference
    0.1%
    Check dated 2026-10-04T08:10:43.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    An additional revision entry labeled v3.7.0 has been added to the study history. The previous revision entry v3.6.6 has been removed from the listed revisions.
    Difference
    0.1%
    Check dated 2026-09-20T03:18:11.000Z thumbnail image

Stay in the know with updates to Neoadjuvant Immunotherapy Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Immunotherapy Combo in Melanoma Clinical Trial page.